Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Medicina Clinica|April 22, 2025
Biomarkers in transthyretin amyloidosis. Present and futureFernando Martínez Valle, Carmen Pérez BocanegraFrontiers in Medicine|July 18, 2022
Co Treatment With Biologic Agents and Immunotherapy in the Setting of irAEs of Difficult ManagementVirginia Robles-Alonso, Fernando Martínez-Valle, Natalia BorruelMedicina Clinica|December 27, 2011
[New trends in the treatment of amyloidosis]Fernando Martínez-Valle, Mercedes Gironella-Mesa, Roser Solans-LaquéMedicina Clinica|December 16, 2017
Update in ethiopathogeny, diagnosis and treatment of the IgG4 related diseaseFernando Martínez-Valle, Olimpia Orozco-Gálvez, Andreu Fernández-CodinaMedicina Clinica|September 2, 2020
Toxicities from immunotherapy: From clinical trials to real-world clinical practiceMar Riveiro-Barciela, Ernesto Trallero-Araguás, Fernando Martínez-Valle, et al.Autoimmunity Reviews|July 17, 2012
Churg-Strauss Syndrome: an evolving paradigmMarc Ramentol-Sintas, Fernando Martínez-Valle, Roser Solans-LaquéAutoimmunity Reviews|May 20, 2008
DNase 1 and systemic lupus erythematosusFernando Martínez Valle, Eva Balada, Josep Ordi-Ros, et al.Clinical Nuclear Medicine|February 25, 2021
Response to Treatment in IgG4-Related Disease Assessed by Quantitative PET/CT ScanOlimpia Orozco-Gálvez, Andreu Fernández-Codina, Marc Simó-Perdigo, et al.Autoimmunity Reviews|December 19, 2016
IgG4-related disease: Evidence from six recent cohortsFernando Martínez-Valle, Andreu Fernández-Codina, Iago Pinal-Fernández, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 14, 2019
Risk of ischaemic events at giant cell arteritis diagnosis according to PET/CT findingsJaume Mestre-Torres, Marc Simó-Perdigó, Fernando Martínez-Valle, et al.Pageof 3